neostigmine methylsulfate and glycopyrrolate
neostigmine methylsulfate and glycopyrrolate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including PREVDUO. Available dosage form: injection.
Drug Details
- Generic Name
- neostigmine methylsulfate and glycopyrrolate
- Brand Names
- PREVDUO
- Application Number
- NDA216903
- Sponsor
- Endo USA
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- NEOSTIGMINE METHYLSULFATE, GLYCOPYRROLATE
Indications and Usage
1 INDICATIONS AND USAGE PREVDUO ® , a fixed dose combination of cholinesterase inhibitor and antimuscarinic agent, is indicated in patients age two years and above for the reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery, while decreasing the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) associated with cholinesterase inhibition following NMBA reversal administration. PREVDUO ® , a fixed dose combination of a cholinesterase inhibitor and antimuscarinic agent, is indicated in patients age two years and above for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery, while decreasing the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) associated with cholinesterase inhibition following NMBA reversal administration ( 1 ).